If basal insulin has been titrated to an acceptable fasting blood glucose level, but A1C remains above target, consider advancing to combination injectable therapy to cover postprandial glucose excursions.
If basal insulin has been titrated to an acceptable fasting blood glucose level, but A1C remainsabove target, consider advancing to combination injectable therapy to cover postprandial glucose excursions.